Form 4 for ORKA Oruka Therapeutics, Inc.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-23 · accession 0000907654-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-23 | 2026-01-23 | ORKA | Dambkowski Carl | Dir | J - Other | $0.00 | +116.5K | 116.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-23 | J | A | 116,483 | $0.00 | 116,483 | D | — | — |